Logo

Tissue-Based Testing

News on immunohistochemistry and other tissue-based testing methods.

ChromaCode Initiates Strategic Shift to Oncology With New Leadership, Digital PCR Lung Cancer Test
Premium

Multiplexed PCR specialist ChromaCode has hired a new CEO and chief business officer to help spearhead its transition to the oncology testing space.

Lunaphore Raises CHF 40M in Series D Financing

The funding for the protein detection and spatial biology company includes a €10 million ($10.9 million) venture debt facility from Norgine Ventures.

RareCyte Moving Into Higher-Plex Spatial Proteomics
Premium

The firm believes its Orion system's combination of multiplexing, data quality, and throughput will help it carve out a space in an increasingly crowded market.

AGBT: NanoString, 10x Genomics Plan High-Resolution Spatial Assays to Detect Thousands of RNAs

At last week's meeting, the firms shared their respective work on developing assays to detect 6,000 RNAs on the CosMx platform and 5,000 RNAs on the Xenium instrument.

Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis

The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics.

Dec 14, 2022

Functional Precision Medicine Firm Kiyatec Raises $18M in Series C Funding Round

Sep 28, 2022

Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders
Premium

Aug 25, 2022

Oncgnostics Epigenetic Cervical Cancer Test Wins Chinese Regulatory Approval

Jul 6, 2022

Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition

Jun 3, 2022

Swiss Immunohistochemistry Firm Lunaphore Shifts Focus to High-Plex Spatial Proteomics
Premium

Jun 3, 2022

Foundation Medicine to Provide Comprehensive Genomic Profiling Tests in Lung Cancer Screening Trial

Jun 1, 2022

Max Planck Team Develops Workflow Combining Single-Cell Imaging With Deep Proteomic Profiling
Premium

May 11, 2022

Thermo Fisher Scientific Invests in Spatial Proteomics Firm Ionpath

Mar 22, 2022

Precision Medicine Firm PreludeDx Closes $20M Funding Round

Mar 8, 2022

Guardant Health Receives Medicare Coverage for Tissue-Based Cancer Test

Sep 9, 2021

RareCyte Secures $24M to Advance Spatial Biology Platform, Expand Globally

Jun 22, 2021

Guardant Health Targets Emerging Treatment Response Market With New ctDNA Product
Premium

Mar 9, 2021

Foundation Medicine, InformedDNA Partner to Expand Genetic Counseling for Cancer Patients

Mar 2, 2021

PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment
Premium

Jan 19, 2021

Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores

Dec 10, 2020

Spatial Analysis Startup Resolve Biosciences Launches With $24M Series A Financing Round

Nov 18, 2020

Indivumed, Ultivue Sign Deal to Integrate Cancer Tissue Analysis Technologies

Sep 22, 2020

Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug

Aug 21, 2020

Owkin Machine Learning Infers RNA Expression From Tissue Images in New Study
Premium

Jul 22, 2020

Ultivue, OracleBio Collaborate on Tissue Biomarker Analysis Workflow

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.